11:36 AM EST, 02/19/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.)

Hims & Hers Health ( HIMS ) shares advanced by over 19% in recent Wednesday trading after the company said it has acquired at-home lab testing provider Sigmund, or Trybe Labs, allowing it to offer at-home blood testing.

Financial terms were not disclosed.

The company said it funded the purchase with cash on hand and expects to introduce at-home testing over the next year.

Price: 69.94, Change: +11.44, Percent Change: +19.56